These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 31778322)

  • 1. The prognostic role of circulating tumor cells in colorectal cancer.
    Nanduri LK; Hissa B; Weitz J; Schölch S; Bork U
    Expert Rev Anticancer Ther; 2019 Dec; 19(12):1077-1088. PubMed ID: 31778322
    [No Abstract]   [Full Text] [Related]  

  • 2. Highly Correlated Recurrence Prognosis in Patients with Metastatic Colorectal Cancer by Synergistic Consideration of Circulating Tumor Cells/Microemboli and Tumor Markers CEA/CA19-9.
    Chu HY; Yang CY; Yeh PH; Hsu CJ; Chang LW; Chan WJ; Lin CP; Lyu YY; Wu WC; Lee CW; Wu JK; Jiang JK; Tseng FG
    Cells; 2021 May; 10(5):. PubMed ID: 34068719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesenchymal marker and LGR5 expression levels in circulating tumor cells correlate with colorectal cancer prognosis.
    Wang W; Wan L; Wu S; Yang J; Zhou Y; Liu F; Wu Z; Cheng Y
    Cell Oncol (Dordr); 2018 Oct; 41(5):495-504. PubMed ID: 29949050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The significant prognostic value of circulating tumor cells in colorectal cancer: A systematic review and meta-analysis.
    Tan Y; Wu H
    Curr Probl Cancer; 2018; 42(1):95-106. PubMed ID: 29277243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating Tumor Cell Count Correlates with Colorectal Neoplasm Progression and Is a Prognostic Marker for Distant Metastasis in Non-Metastatic Patients.
    Tsai WS; Chen JS; Shao HJ; Wu JC; Lai JM; Lu SH; Hung TF; Chiu YC; You JF; Hsieh PS; Yeh CY; Hung HY; Chiang SF; Lin GP; Tang R; Chang YC
    Sci Rep; 2016 Apr; 6():24517. PubMed ID: 27075165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biology and significance of circulating and disseminated tumour cells in colorectal cancer.
    Steinert G; Schölch S; Koch M; Weitz J
    Langenbecks Arch Surg; 2012 Apr; 397(4):535-42. PubMed ID: 22350614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating tumor cells as a longitudinal biomarker in patients with advanced chemorefractory, RAS-BRAF wild-type colorectal cancer receiving cetuximab or panitumumab.
    Musella V; Pietrantonio F; Di Buduo E; Iacovelli R; Martinetti A; Sottotetti E; Bossi I; Maggi C; Di Bartolomeo M; de Braud F; Daidone MG; Cappelletti V
    Int J Cancer; 2015 Sep; 137(6):1467-74. PubMed ID: 25704501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating tumor cell levels are elevated in colorectal cancer patients with high tumor burden in the liver.
    Kaifi JT; Kunkel M; Dicker DT; Joude J; Allen JE; Das A; Zhu J; Yang Z; Sarwani NE; Li G; Staveley-O'Carroll KF; El-Deiry WS
    Cancer Biol Ther; 2015; 16(5):690-8. PubMed ID: 25785486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic and clinicopathological significance of circulating tumor cells detected by RT-PCR in non-metastatic colorectal cancer: a meta-analysis and systematic review.
    Yang C; Zou K; Zheng L; Xiong B
    BMC Cancer; 2017 Nov; 17(1):725. PubMed ID: 29115932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic and Therapeutic Significance of Circulating Tumor Cell Phenotype Detection Based on Epithelial-Mesenchymal Transition Markers in Early and Midstage Colorectal Cancer First-Line Chemotherapy.
    Lu G; Lu Z; Li C; Huang X; Luo Q
    Comput Math Methods Med; 2021; 2021():2294562. PubMed ID: 34777560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating tumor cells as biomarkers in head and neck cancer: recent advances and future outlook.
    Tinhofer I; Staudte S
    Expert Rev Mol Diagn; 2018 Oct; 18(10):897-906. PubMed ID: 30199647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of circulating tumor cells as prognostic marker in resected stage III colorectal cancer.
    Sotelo MJ; Sastre J; Maestro ML; Veganzones S; Viéitez JM; Alonso V; Grávalos C; Escudero P; Vera R; Aranda E; García-Alfonso P; Gallego-Plazas J; Lopez C; Pericay C; Arrivi A; Vicente P; Ballesteros P; Elez E; López-Ladrón A; Díaz-Rubio E
    Ann Oncol; 2015 Mar; 26(3):535-41. PubMed ID: 25515656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating tumour cells and outcome in non-metastatic colorectal cancer: a prospective study.
    Bork U; Rahbari NN; Schölch S; Reissfelder C; Kahlert C; Büchler MW; Weitz J; Koch M
    Br J Cancer; 2015 Apr; 112(8):1306-13. PubMed ID: 25867263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection and Clinical Significance of Circulating Tumor Cells in Colorectal Cancer--20 Years of Progress.
    Hardingham JE; Grover P; Winter M; Hewett PJ; Price TJ; Thierry B
    Mol Med; 2015 Oct; 21 Suppl 1(Suppl 1):S25-31. PubMed ID: 26605644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Potential of Circulating Tumor Cells in Colorectal Cancer: A Prospective Study.
    Baek DH; Kim GH; Song GA; Han IS; Park EY; Kim HS; Jo HJ; Ko SH; Park DY; Cho YK
    Clin Transl Gastroenterol; 2019 Jul; 10(7):e00055. PubMed ID: 31246593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of epithelial-mesenchymal transition typing of circulating tumour cells in colorectal cancer.
    Hou J; Guo C; Lyu G
    Colorectal Dis; 2020 May; 22(5):581-587. PubMed ID: 31868956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plastin3 is a novel marker for circulating tumor cells undergoing the epithelial-mesenchymal transition and is associated with colorectal cancer prognosis.
    Yokobori T; Iinuma H; Shimamura T; Imoto S; Sugimachi K; Ishii H; Iwatsuki M; Ota D; Ohkuma M; Iwaya T; Nishida N; Kogo R; Sudo T; Tanaka F; Shibata K; Toh H; Sato T; Barnard GF; Fukagawa T; Yamamoto S; Nakanishi H; Sasaki S; Miyano S; Watanabe T; Kuwano H; Mimori K; Pantel K; Mori M
    Cancer Res; 2013 Apr; 73(7):2059-69. PubMed ID: 23378342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating Tumor Cells Undergoing EMT Provide a Metric for Diagnosis and Prognosis of Patients with Hepatocellular Carcinoma.
    Qi LN; Xiang BD; Wu FX; Ye JZ; Zhong JH; Wang YY; Chen YY; Chen ZS; Ma L; Chen J; Gong WF; Han ZG; Lu Y; Shang JJ; Li LQ
    Cancer Res; 2018 Aug; 78(16):4731-4744. PubMed ID: 29915159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of circulating tumor cells in drainage venous blood from colorectal cancer patients using a new filtration and cytology-based automated platform.
    Tsutsuyama M; Nakanishi H; Yoshimura M; Oshiro T; Kinoshita T; Komori K; Shimizu Y; Ichinosawa Y; Kinuta S; Wajima K; Sakakibara Y; Yatabe Y; Ito S; Kodera Y
    PLoS One; 2019; 14(2):e0212221. PubMed ID: 30811434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal enumeration and cluster evaluation of circulating tumor cells improve prognostication for patients with newly diagnosed metastatic breast cancer in a prospective observational trial.
    Larsson AM; Jansson S; Bendahl PO; Levin Tykjaer Jörgensen C; Loman N; Graffman C; Lundgren L; Aaltonen K; Rydén L
    Breast Cancer Res; 2018 Jun; 20(1):48. PubMed ID: 29884204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.